IRadimed Corporation (IRMD)
| Market Cap | 415.86M |
| Revenue (ttm) | 35.28M |
| Net Income (ttm) | 4.57M |
| Shares Out | 12.31M |
| EPS (ttm) | 0.36 |
| PE Ratio | 92.81 |
| Forward PE | 41.67 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 82,000 |
| Open | 33.76 |
| Previous Close | 33.76 |
| Day's Range | 32.91 - 34.15 |
| 52-Week Range | 20.52 - 40.51 |
| Beta | 1.05 |
| Analysts | Buy |
| Price Target | 38.00 (+12.8%) |
| Est. Earnings Date | Oct 29, 2021 |
About IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensor...
Financial Performance
In 2020, IRadimed's revenue was $31.72 million, a decrease of -17.65% compared to the previous year's $38.52 million. Earnings were $1.37 million, a decrease of -85.79%.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for IRadimed stock is "Buy" and the 12-month stock price forecast is 38.00.
News
IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results
WINTER SPRINGS, Fla., July 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices ...
IRadimed (IRMD) Earnings Expected to Grow: Should You Buy?
IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
iRadimed (IRMD) Stock Jumps 11.3%: Will It Continue to Soar?
iRadimed (IRMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t...
IRADIMED CORPORATION to Hold 2021 Second Quarter Financial Results Conference Call on July 30th
WINTER SPRINGS, Fla., July 07, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 second quarter financial results before the market open...
Here's What Could Help iRadimed (IRMD) Maintain Its Recent Price Strength
iRadimed (IRMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our sho...
IRadimed (IRMD) Q1 Earnings and Revenues Top Estimates
iRadimed (IRMD) delivered earnings and revenue surprises of 44.44% and 10.34%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
IRADIMED CORPORATION Announces First Quarter 2021 Financial Results
WINTER SPRINGS, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices...
Earnings Outlook for iRadimed
iRadimed (NASDAQ:IRMD) announces its next round of earnings this Friday, April 30. Here is Benzinga's look at iRadimed's Q1 earnings report.
IRADIMED CORPORATION to Hold 2021 First Quarter Financial Results Conference Call on April 30th
WINTER SPRINGS, Fla., April 09, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 first quarter financial results before the market open...
IRADIMED CORPORATION to Hold 2020 Fourth Quarter Financial Results Conference Call on February 4th
WINTER SPRINGS, Fla., Jan. 27, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 fourth quarter financial results before the market open...
A Trio of Stocks Growing Revenue Per Share Fast
The S&P 500 Index stocks saw their aggregate trailing 12-month real revenue per share rise at a compound average growth rate (CAGR) of 1.97% per annum over the past five years, which occurred alongside ...
IRadimed Corporation (IRMD) CEO Roger Susi on Q3 2020 Results - Earnings Call Transcript
IRadimed Corporation (IRMD) CEO Roger Susi on Q3 2020 Results - Earnings Call Transcript
IRadimed Corporation's (IRMD) CEO Roger Susi On Q3 2020 Results - Quick Version Earnings Call Transcript
IRadimed Corporation's (IRMD) CEO Roger Susi On Q3 2020 Results - Quick Version Earnings Call Transcript
IRadimed (IRMD) Q3 Earnings and Revenues Top Estimates
iRadimed (IRMD) delivered earnings and revenue surprises of 120.00% and 3.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
IRADIMED CORPORATION Announces Third Quarter 2020 Financial Results
WINTER SPRINGS, Fla., Oct. 30, 2020 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices ...
Analysts Estimate iRadimed (IRMD) to Report a Decline in Earnings: What to Look Out for
IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRADIMED CORPORATION to Hold 2020 Third Quarter Financial Results Conference Call on October 30th
WINTER SPRINGS, Fla., Oct. 08, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 third quarter financial results before the market opens...
IRadimed Corp (IRMD) CEO Roger Susi on Q2 2020 Results - Earnings Call Transcript
IRadimed Corp (IRMD) CEO Roger Susi on Q2 2020 Results - Earnings Call Transcript
IRadimed (IRMD) Beats Q2 Earnings and Revenue Estimates
iRadimed (IRMD) delivered earnings and revenue surprises of 225.00% and 22.96%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
IRADIMED CORPORATION Announces Second Quarter 2020 Financial Results
WINTER SPRINGS, Fla., July 30, 2020 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical device...
Earnings Preview: iRadimed (IRMD) Q2 Earnings Expected to Decline
IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRADIMED CORPORATION to Hold 2020 Second Quarter Financial Results Conference Call on July 30th
WINTER SPRINGS, Fla., July 16, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 second quarter financial results before the market op...
IRADIMED CORPORATION Names Roger Susi as President and Chief Executive Officer
WINTER SPRINGS, Fla., May 29, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company’s P...
IRADIMED CORPORATION Announces Issuance of U.S. Patent
Latest patent expands previous claims around IRADIMED’s wireless communication as used to remotely control an IV pump Latest patent expands previous claims around IRADIMED’s wireless communication as us...
IRadimed's (IRMD) CEO Leslie McDonnell on Q1 2020 Results - Earnings Call Transcript
IRadimed's (IRMD) CEO Leslie McDonnell on Q1 2020 Results - Earnings Call Transcript